Technical Analysis for NVAX - Novavax, Inc.

Grade Last Price % Change Price Change
grade A 2.05 -2.38% -0.05
NVAX closed down 2.38 percent on Friday, January 18, 2019, on 1.13 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical NVAX trend table...

Date Alert Name Type % Chg
Jan 18 Fell Below 20 DMA Bearish 0.00%
Jan 18 50 DMA Support Bullish 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 17 Narrow Range Bar Range Contraction -2.38%
Jan 17 NR7 Range Contraction -2.38%
Jan 17 Wide Bands Range Expansion -2.38%
Jan 16 MACD Bearish Signal Line Cross Bearish -1.91%
Jan 16 Narrow Range Bar Range Contraction -1.91%
Jan 16 Wide Bands Range Expansion -1.91%
Jan 15 Crossed Above 20 DMA Bullish -3.30%

Older signals for NVAX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company's technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines. Its vaccine candidates target seasonal influenza, pandemic (H5N1) influenza, and respiratory syncytial virus (RSV). The company, through its joint venture, CPL Biologics Private Limited, engages in developing seasonal and pandemic influenza, and rabies vaccine candidates. The company has a licensing agreement with LG Life Sciences, Ltd. to use the company's VLP technology to develop and sell the influenza vaccines in South Korea and other countries; and a clinical development agreement with PATH Vaccine Solutions to develop RSV vaccine candidate. The company was founded in 1987 and is headquartered in Rockville, Maryland.
Is NVAX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.75
52 Week Low 1.15
Average Volume 8,757,463
200-Day Moving Average 1.7012
50-Day Moving Average 2.0044
20-Day Moving Average 2.0545
10-Day Moving Average 2.17
Average True Range 0.1467
ADX 13.85
+DI 18.6885
-DI 20.1976
Chandelier Exit (Long, 3 ATRs ) 1.9299
Chandelier Exit (Short, 3 ATRs ) 2.1401
Upper Bollinger Band 2.3639
Lower Bollinger Band 1.7451
Percent B (%b) 0.49
BandWidth 30.11925
MACD Line 0.026
MACD Signal Line 0.037
MACD Histogram -0.0111
Fundamentals Value
Market Cap 594.29 Million
Num Shares 290 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -2.66
Price-to-Sales 13.78
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.23
Resistance 3 (R3) 2.23 2.18 2.20
Resistance 2 (R2) 2.18 2.13 2.18 2.19
Resistance 1 (R1) 2.11 2.10 2.09 2.11 2.18
Pivot Point 2.06 2.06 2.04 2.06 2.06
Support 1 (S1) 1.99 2.01 1.97 1.99 1.92
Support 2 (S2) 1.94 1.98 1.94 1.91
Support 3 (S3) 1.87 1.94 1.90
Support 4 (S4) 1.87